Principal Investigator:
Yvonne Chiu, MD
Medical College of Wisconsin
Overview:
Morphea is a disease that causes issues in the skin, muscles, bones, and other body parts. It has two phases: an active phase and an inactive phase. Detecting whether morphea is active is difficult but important. Treating it during the active phase prevents lasting damage, while avoiding treatment when it’s not active saves patients from unnecessary medication. Doctors have tried various methods to assess morphea activity, but they have not yet found a perfect one. To help pediatric dermatology researchers, a research team created a new tool called the Morphea Activity Measure (MAM) and plans to make another one, the Morphea Damage Measure (MDM). Together, they will form the Morphea Activity and Damage Measure (MADM). Developing MADM is essential because we need a better way to tell if morphea is active, benefitting patients and future research.
Status:
This project was funded by a 2023 Career Bridge Research Grant.
